Applications must be submitted by a single institution for one service, technology, process, project or product.
Applications must comply with all relevant laws and regulations, and shall not involve false claims, infringement, counterfeiting, or violations of intellectual property rights.
All submitted documents and supporting reports must be true and accurate. Any falsification or misrepresentation will lead to disqualification or termination of certification, a three-year prohibition on re-application, and full legal liability borne by the applicant.
The certification body and review committee are obliged to maintain confidentiality of application materials. However, all submitted documents, attachments, and physical products will not be returned, regardless of review outcome.
Once the review process has commenced, application fees are non-refundable, regardless of withdrawal or disqualification.
Certified items, upon receipt of official notification, are required to sign the "SNQ License Agreement" before being formally authorized to use the SNQ Mark and its related identifiers.
Recognizing excellence in Imported Prescription Medications, Taiwan-Origin Prescription Medications, Imported OTC Drugs, and Taiwan-Origin OTC Drugs.
Applies to｜Pharmaceuticals, Traditional Chinese Medicines, Medical & Healthcare Devices, Clinical Support Services & Products, Smart Health Technology, Aging Health & Long-Term Care, Nutritional Health, Cosmetics, Epidemic Prevention Products, and Animal Care Services & Products categories
All applications must be submitted online. Visit the SNQ official website (www.snq.org.tw) homepage and then click "Apply for Certification".
Log in to the "Application & Review Data Maintenance Portal" to complete the application form and download the required document templates.
Pay the application fees and upload the required materials as specified. The application is considered complete only after the organizer confirms receipt.
Complete the online application form, print it, affix the institution's official and small seals, then scan and upload the signed copy as a PDF.
Prepare the plan per each category's template and upload as an unencrypted PDF. (Content must be complete and include supporting evidence.)
(1) 3–5 photos (jpg or png, at least 1000 × 750px in 4:3 landscape, 300dpi or higher). Product entries must include a background-removed hero photo, centred and scaled so the product is fully visible with no part of it clipped by any edge; other close-up shots are exempt from this rule. Technology or service entries should show the theme, workflow, features, and team; nutritional health products additionally require close-ups of the packaging and labelling. (2) Applicant logo (jpg or png, 300dpi or higher).
Provide 10 samples with complete inner and outer packaging identical to what is sold on the market; if multiple specifications exist, submit 10 of each. Deliver in person or by registered mail to "1F, No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei 115 - SNQ National Quality Mark Administrative Team". (Skip if no physical product exists; for oversized products, contact the coordinator to confirm the arrangement.)
Pharmaceuticals, Traditional Chinese Medicines, Medical & Healthcare Devices, Clinical Support Services & Products, Smart Health Technology, Aging Health & Long-Term Care, Nutritional Health, Cosmetics, Epidemic Prevention Products, and Animal Care Services & Products categories.
Applications that do not pass review (including ineligibility or failure at any stage, excluding revisions) will receive a refund within 30 days of the result announcement, after deducting NT$ 30,000 for administrative and review fees. Nutritional health products run in two application rounds; entries rejected in the first round may reapply for the second round after improvements, to encourage quality improvement.
Series product bundle applications are priced at NT$ 120,000 for two items, plus NT$ 20,000 for each additional item. Failed applications are refunded after deducting NT$ 30,000 for administrative and review fees.
The organizer notifies applicants of the review results by formal written letter each December and publishes the selected list on the SNQ official website. Each selected unit must sign the "SNQ National Quality Mark Usage Authorization Agreement" with the organizer before the selected item may officially use the "SNQ National Quality Mark".
After the announcement, the organizer randomly inspects the quality and mark usage of selected items through market channels; any violation of authority regulations or significant quality defect will result in revoked mark authorization, with full legal responsibility borne by the applicant.
The organizer conducts unscheduled on-site visits or paper reviews of manufacturing facilities; for factories located overseas, alternative measures beyond on-site visits are defined.
To ensure certified items maintain their quality, the annual renewal process begins each July. Applicants must submit renewal applications with all required documents at least three months prior to certification expiry.
Approved renewals extend the authorization to use the SNQ Mark and allow continued participation in related promotional programs. The renewed authorization period is from January 1 to December 31 of the following year.
Renewal applicants may also apply for the current year's National Biotechnology & Medical Care Quality Award in accordance with that year's application procedures.
Applicants who fail to submit a renewal application within the specified timeframe will lose authorization to use the SNQ Mark upon expiry and will not be eligible for further renewal.
The renewal administrative and review fees are NT$ 20,000. Applicants who also enter the current year's National Biotechnology & Medical Care Quality Award pay NT$ 30,000. (No additional refund is given if the renewal or award bid is unsuccessful.)
Efficacy, safety, and practical clinical benefits.
Registered enterprises and institutions (including manufacturers, importers, and agents).
Strengthen patient outcomes, ensure medication safety and regulatory compliance, encourage pharmaceutical innovation, and expand domestic and international market influence.
